Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Saxagliptin on Endothelial Progenitor Cells in Early Type 2 Diabetes
NCT02024477Phase 4Completed
- Sponsor
- George Washington University
- Start
- Nov 2013
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by George Washington University. Started Nov 2013; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02024477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02024477.